AI.gnosis is redefining autism diagnosis with AI-powered tools designed to help parents understand their child’s unique way of experiencing the world. By enabling early detection of autism and other neurodevelopmental concerns from the comfort of home, AIgnosis provides parents with valuable insights when they matter most. With a strong focus on accuracy and reliability, the startup ensures a non-invasive approach tailored to meet families’ needs. Early diagnosis plays a crucial role in improving developmental outcomes, and AIgnosis is bridging the gap between uncertainty and timely intervention, giving parents the confidence to seek the right support at the right time.
Founded by Raksheet Jain and Divyansh Mangal, this Jaipur-based startup aims to revolutionize the autism diagnosis ecosystem through AI-driven solutions that not only detect autism early but also provide therapeutic support. The duo, seeking ₹50 lakh for 4% equity, presented their brand’s impact with conviction, earning curiosity and praise from the sharks, who particularly appreciated the thoughtful name of their venture. Their journey began at Divyansh’s father’s childcare center, where they conducted extensive research on autism and its challenges. Through their findings, they recognized the urgent need for a more accessible and technology-driven approach to early diagnosis. AIgnosis’ solution simplifies the detection process, bridging the critical gap between initial identification and therapy, ensuring that children receive timely support without delays or misdiagnosis.
While their innovation impressed the sharks, Varun Dua and Peyush Bansal raised concerns about scalability and affordability, questioning how the company planned to make its services widely available. The founders defended their approach, emphasizing their mission to create an affordable and impactful solution for families across different socioeconomic backgrounds. After careful deliberation, Vineeta Singh and Anupam Mittal opted out, while Peyush Bansal, Aman Gupta, and Varun Dua saw immense potential in AIgnosis and made investment offers. The final deal was sealed at ₹1 crore for 8% equity, bringing all three sharks on board and providing AIgnosis with the necessary support to scale its vision.
AIgnosis’ journey is a testament to how technology, when applied with purpose, can drive real change in people’s lives. By combining artificial intelligence with a deep understanding of neurodevelopmental conditions, the startup is making autism diagnosis more accessible, accurate, and timely. With backing from three prominent investors, AIgnosis is now well-positioned to expand its reach, improve its AI models, and enhance therapeutic solutions. More than just a business, AIgnosis represents a movement toward early intervention and inclusive healthcare, proving that entrepreneurship can be a powerful force for social good.
